Physician profile
Avery Johnson
NPI 1972116978
$2,748.25
in general payments reported to CMS, 2019-2025
18 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $217 · 2024: $1,142 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,748.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $464.16 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $371.09 | 2023-2025 | |
| Abbott Laboratories | $359.93 | 2024-2025 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $302.48 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.96 | 2024-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $154.38 | 2023-2025 | Onpattro, Amvuttra |
| Merck Sharp & Dohme LLC | $148.34 | 2024-2025 | Verquvo, Lagevrio |
| Edwards Lifesciences Corporation | $140.67 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $126.93 | 2024-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $99.22 | 2025 | |
| Esperion Therapeutics, INC. | $79.62 | 2024-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $70.20 | 2024 | Xarelto |
| Abiomed | $70.16 | 2024 | Impella |
| Scpharmaceuticals INC. | $64.41 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.91 | 2023-2024 | Lifevest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $32.40 | 2025 | Wegovy |
| Baxter Healthcare | $24.39 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Vivaquant INC, Dba Rhythm Express | $21.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avery Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.